Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local Therapy

Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local Therapy

This study aimed to evaluate the outcomes and identify the predictive factors of a bladder-preservation approach incorporating maximal transurethral resection of bladder tumor (TURBT) coupled with either pembrolizumab or chemotherapy for patients diagnosed with muscle-invasive bladder cancer (MIBC)...

Full description

Bibliographic Details
Main Authors: Pei-Hung Chang, Hung-Yi Chen, Yueh-Shih Chang, Po-Jung Su, Wen-Kuan Huang, Cheng-Feng Lin, Jason Chia-Hsun Hsieh, Chun-Te Wu
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Cancers
Subjects:
bladder preservation
neoadjuvant chemotherapy
pembrolizumab
muscle-invasive bladder cancer
clinical complete remission
Online Access:https://www.mdpi.com/2072-6694/16/5/894

Internet

https://www.mdpi.com/2072-6694/16/5/894

Similar Items